Agfa-Gevaert NV

Agfa-Gevaert NV

0.41
EUR
0.00
(0.00%)
-0.61EPS
65.49MMarket Cap
Nov 10Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
17.08
15.62
15.77
15.12
14.56
13.06
11.77
10.19
11.26
7.33
7.43
7.35
7.01
6.95
Basic EPS, GAAP
0.24
0.3
0.37
0.42
0.22
-0.14
-0.32
3.65
-0.11
-1.41
-0.66
-0.59
-0.46
-0.7
Free Cash Flow per Basic Share
0.4
0.68
0.67
0.58
-0.04
-0.26
0.73
-0.91
-0.74
-0.64
-0.19
-0.03
0.41
0.25
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.94
0.55
1.36
1.28
1.64
1.5
0.49
3.4
3.94
3.36
2.55
2.09
1.64
1.49
Tangible Book Value per Share
-1.75
-3.11
-2.35
-2.42
-1.87
-2.17
-3.33
1.39
1.81
1.55
0.87
0.37
-0.09
-0.08
Basic Weighted Avg Shares
168
168
168
168
168
168
168
168
156
156
155
155
155
155
Sales/Revenue/Turnover
2,865
2,620
2,646
2,537
2,443
2,191
1,975
1,709
1,760
1,145
1,150
1,138
1,086
1,074
Operating Margin (%)
7.71
6.15
6.76
7.69
6.22
3.33
3.14
1.4
1.14
-3.32
0.43
0.97
0.74
-5.87
Depreciation Expense
86
69
61
72
56
54
94
69
62
63
42
42
36
36
Net Income, GAAP
41
50
62
70
37
-24
-53
613
-17
-221
-102
-92
-71
-108
Effective Tax Rate (%)
46.74
23.38
18.39
30.43
54.08
154.55
- -
- -
1,500
- -
- -
- -
- -
- -
Profit Margin (%)
1.43
1.91
2.34
2.76
1.51
-1.1
-2.68
35.87
-0.97
-19.3
-8.87
-8.08
-6.54
-10.06
Working Capital
699
550
567
568
563
607
473
952
742
568
404
397
316
314
LT Debt
319
125
137
74
47
219
224
54
46
41
68
141
152
177
Total Equity
368
146
268
252
307
290
130
621
686
561
396
325
256
232
Return on Invested Capital (%)
12.33
15.36
22.93
22.87
13.54
-5.99
- -
- -
-16.1
- -
- -
- -
- -
- -
Return on Capital (%)
10.17
13.84
19.04
21.8
12.41
-11.44
- -
- -
-29.69
- -
- -
- -
- -
- -
Return on Common Equity (%)
17.9
23.92
38.63
31.6
15.1
-9.11
-31.64
187.75
-2.83
-38.37
-22.3
-25.63
-24.61
-40

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
17
12
18
LT Borrowings
111
141
- -
LT Finance Leases
41
43
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
155
155
155
Market Capitalization
73
72
65

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
719
726
704
Cash, Cash Equivalents & STI
91
84
68
Accounts Receivable, Net
169
143
130
Inventories
254
330
342
Total Current Liabilities
403
390
390
Payables & Accruals
- -
- -
- -
ST Debt
17
12
18
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.65%
-15.26%
-21.23%
Free Cash Flow
-195.89%
-373.93%
-1,675%
Net Income, GAAP
-32.41%
202.15%
-22.83%
Sales/Revenue/Turnover
-7.86%
-7.43%
-4.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
250
286
277
325
1,138
2025
242
281
257
306
1,086
2026
236
275
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.14
0.03
-0.08
-0.4
-0.59
2025
-0.13
0.2
-0.12
-0.4
-0.46
2026
-0.08
-0.1
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Pascal Juéry
Full Time Employees
4,256
Sector
Consumer durables
Industry
Electronics/Appliances
Address
Septestraat 27 Mortsel VL Belgium 2640
IPO Date
May 31, 1999
Website
agfa.com
Business
Agfa-Gevaert N.V. (AFGVF) develops, produces and distributes analog and digital imaging systems and IT solutions primarily for the healthcare sector, printing industry and specific industrial applications; its core offerings span three divisions including HealthCare IT with enterprise imaging platforms, XERO Universal Viewer and cloud-based solutions for radiology workflow management; Radiology Solutions encompassing direct radiography flat panels, computed radiography systems, X-ray artificial intelligence tools and medical films; and Digital Print & Chemicals featuring inks, large-format printers, synthetic paper, offset plates, prepress systems and hydrogen membranes under ZIRFON for green energy applications. Founded in 1964 through the merger of Agfa AG (established 1867) and Gevaert Photo-Producten N.V., the company maintains headquarters in Mortsel, Belgium, with major production and research facilities in Belgium, the United States, Canada, Germany, Austria, China and Brazil; it operates sales organizations in over 40 countries worldwide, targeting hospitals, diagnostic centers, printers and industrial clients. Recent developments include a major deal with Alliance Medical for cloud-based Enterprise Imaging at 120 UK and Ireland sites, a strategic partnership with DHS for print engines in monochrome and polychrome toner lines, resolution of the long-standing AgfaPhoto legal dispute via favorable arbitration, a new revolving credit facility with four financial institutions, launch of advanced inkjet centers and printers, a self-funding cost-reduction program targeting 50 million euro savings by 2027 in traditional film activities with initial benefits in late 2025, and sustained growth in Green Hydrogen Solutions featuring ZIRFON membranes for global projects.